Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy

NCT04571216 is registered in ClinicalTrials.gov with NFL Biosciences SAS as lead sponsor.

NCT NCT04571216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04571216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy
Lead sponsor
NFL Biosciences SAS
Phase
Phase 2
Overall status
Completed
Start date
April 12, 2021
Completion date
April 12, 2024
Enrollment
318 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, smoking cessation